JUNIUS DANIEL M 4

What Happened
Daniel M. Junius, a director of IDEXX Laboratories (IDXX), had 257 restricted stock units (RSUs) vest on May 7, 2026 and converted those RSUs into 257 shares. The acquisition is recorded at $0.00 per share (no exercise price). The filing also shows a related derivative disposition entry for 257 units (reflecting the conversion/cancellation of the RSU award).

Key Details

• Transaction date: May 7, 2026 (reported on Form 4 filed May 11, 2026).
• Reported transactions: Acquired 257 shares @ $0.00 (conversion of RSUs); corresponding derivative disposition of 257 units (N/A price).
• Footnote: Each restricted stock unit represented a contingent right to one share and vested in one installment on May 7, 2026.
• Shares owned after the transaction: Not reported in the provided excerpt.
• Filing timeliness: Filed May 11, 2026 for a May 7 transaction — within the standard two-business-day reporting window (timely).

Context
This was a standard RSU vesting event (derivative conversion) rather than an open-market purchase or sale. The $0.00 price reflects that there was no exercise price for the vested RSUs. The separate derivative disposition line is typical bookkeeping for the cancellation/conversion of the RSU award and does not necessarily indicate a market sale of shares.